Top Story

FDA: Future will bring more targeted therapies for psoriasis

September 2, 2014

Psoriasis treatments have evolved from a step-by-step approach to more targeted therapies catered to the specific needs of each patient, according to a consumer update from the U.S. Food and Drug Administration.

“Tomorrow’s treatments will become even more personalized, because the drugs in development now are targeting different aspects of the immune system,” Melinda L. McCord, MD, a dermatologist at the FDA, said in the consumer update.

Allergan responds to Valeant, Pershing Square counterclaims

September 2, 2014
Allergan has filed an answer in the U.S. District Court for the Central District of California in response to Valeant Pharmaceuticals and Pershing Square Capital…
In the Journals

Skin trauma may lead to development of morphea lesions in certain patients

September 1, 2014
Researchers have reported an association between skin trauma and the development of morphea lesions at the site of antecedent injury, suggesting that that elective…
In the Journals

Surgery remains ‘gold standard’ for basal cell carcinoma

September 1, 2014
Surgery remains the ideal treatment for patients with basal cell carcinoma, according to results of an evidence review.Researchers with Columbia University Medical…
More News Headlines »
Meeting News Coverage Video

'Magic Wand Project' for clinical dermatology research explained

April 7, 2014
DENVER — R. Rox Anderson, MD, professor of dermatology at Harvard Medical School and director of the Wellman…
More »